0001169245-15-000001.txt : 20150312 0001169245-15-000001.hdr.sgml : 20150312 20150312103536 ACCESSION NUMBER: 0001169245-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150312 DATE AS OF CHANGE: 20150312 EFFECTIVENESS DATE: 20150312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-235733 FILM NUMBER: 15694811 BUSINESS ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-535-8861 MAIL ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 D 1 primary_doc.xml X0707 D LIVE 0001169245 PhaseBio Pharmaceuticals Inc 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 610.981.6500 DELAWARE Phase Biosciences Inc DT BIOSCIENCES INC Corporation true Jonathan Mow 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Joel Sussman 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Ashutosh Chilkoti 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Clay Thorp 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Asish K. Xavier 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Guy Fish 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director James Barrett 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Justin Klein 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Robert Ingram 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Michael Gutch 1 Great Valley Parkway Suite 30 Malvern PA PENNSYLVANIA 19355 Director Biotechnology Decline to Disclose 06b false 2015-02-26 true true true Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof false 0 40000000 20000000 20000000 false 8 0 0 900000 true false PhaseBio Pharmaceuticals Inc /s/ Joel Sussman Joel Sussman Chief Financial Officer 2015-03-10